Multiple Myeloma: Diagnosis and Risk Assessment | Dana-Farber Cancer Institute
1,678 views · Published 24 February 2017 · 43:52 · Indexed 29 October 2026
Channel: Dana-Farber Cancer Institute · 2017 · Science & Technology
Nikhil C. Munshi, MD, Director of Basic and Correlative Science at the Jerome Lipper Multiple Myeloma Cancer and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School, discusses diagnosis and risk assessment in multiple myeloma. This presentation was originally given at the Multiple Myeloma Patient Education Symposium on Dec. 10, 2016 in Boston, MA.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute